Anand et al., 2022 - Google Patents
Polyphenols and their nanoformulations: Protective effects against human diseasesAnand et al., 2022
View HTML- Document ID
- 9122420889190153976
- Author
- Anand S
- Sowbhagya R
- Ansari M
- Alzohairy M
- Alomary M
- Almalik A
- Ahmad W
- Tripathi T
- Elderdery A
- Publication year
- Publication venue
- Life
External Links
Snippet
Polyphenols are the secondary metabolites synthesized by the plants as a part of defense machinery. Owing to their antioxidant, anti-inflammatory, anticancerous, antineoplastic, and immunomodulatory effects, natural polyphenols have been used for a long time to prevent …
- 235000013824 polyphenols 0 title abstract description 97
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48961—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Anand et al. | Polyphenols and their nanoformulations: Protective effects against human diseases | |
| Yang et al. | Nanoformulations to enhance the bioavailability and physiological functions of polyphenols | |
| Khalil et al. | Nanoantioxidants: Recent trends in antioxidant delivery applications | |
| Tagde et al. | The multifaceted role of curcumin in advanced nanocurcumin form in the treatment and management of chronic disorders | |
| Kyriakoudi et al. | Innovative delivery systems loaded with plant bioactive ingredients: Formulation approaches and applications | |
| Munin et al. | Encapsulation of natural polyphenolic compounds; a review | |
| Ranjha et al. | Biocompatible nanomaterials in food science, technology, and nutrient drug delivery: recent developments and applications | |
| Zuccari et al. | Formulation strategies to improve oral bioavailability of ellagic acid | |
| Pinheiro et al. | Nanotechnology innovations to enhance the therapeutic efficacy of quercetin | |
| Qin et al. | Preparation of bioactive polysaccharide nanoparticles with enhanced radical scavenging activity and antimicrobial activity | |
| Conte et al. | Recent advances in nanoparticle-mediated delivery of anti-inflammatory phytocompounds | |
| Aldawsari et al. | Preparation and characterization of chitosan coated plga nanoparticles of resveratrol: Improved stability, antioxidant and apoptotic activities in H1299 lung cancer cells | |
| Zafar et al. | Recent developments in the reduction of oxidative stress through antioxidant polymeric formulations | |
| Witika et al. | Enhancement of biological and pharmacological properties of an encapsulated polyphenol: Curcumin | |
| Rudrapal et al. | Nanodelivery of dietary polyphenols for therapeutic applications | |
| Moreno-Vásquez et al. | Characterization of epigallocatechin-gallate-grafted chitosan nanoparticles and evaluation of their antibacterial and antioxidant potential | |
| Abdul Rahim et al. | Recent advances in nanoencapsulation systems using PLGA of bioactive phenolics for protection against chronic diseases | |
| AbouAitah et al. | Nanomedicine as an emerging technology to foster application of essential oils to fight cancer | |
| Ferreira et al. | Flavonoids-based delivery systems towards cancer therapies | |
| De Marco | Zein microparticles and nanoparticles as drug delivery systems | |
| Bonferoni et al. | Nose-to-brain delivery of antioxidants as a potential tool for the therapy of neurological diseases | |
| Razura-Carmona et al. | Mangiferin-loaded polymeric nanoparticles: optical characterization, effect of Anti-Topoisomerase I, and Cytotoxicity | |
| Rosales et al. | Nanotechnology as a tool to mitigate the effects of intestinal microbiota on metabolization of anthocyanins | |
| Trindade et al. | Increasing the power of polyphenols through nanoencapsulation for adjuvant therapy against cardiovascular diseases | |
| Pepe et al. | Curcumin-loaded nanoparticles based on amphiphilic hyaluronan-conjugate explored as targeting delivery system for neurodegenerative disorders |